Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Comparison of contrast-enhanced mammography and contrast-enhanced breast tomosynthesis

13/11/2018

Contrast-enhanced mammography is a promising new technique that is already commercially available. By utilizing an iodinated contrast agent, cancers are enhanced that sometimes do not show up on digital mammography. Therefore, it can offer a much higher sensitivity than digital mammography alone.

Paul Fisher in Stony Brook, New York (USA) and his team are conducting research on contrast-enhanced breast tomosynthesis. So far they’ve compared contrast-enhanced breast tomosynthesis with contrast-enhanced mammography for lesion assessment, contrast enhancement, and margin identification with respect to dose. They’ve also evaluated synthetic contrast-enhanced mammography images.

Listen to Paul Fisher present his current findings and learn about the impact that contrast-enhanced breast tomosynthesis may have in the future. Watch the video!